| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |